Market Cap 13.40M
Revenue (ttm) 0.00
Net Income (ttm) -41.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 83,800
Avg Vol 152,574
Day's Range N/A - N/A
Shares Out 4.93M
Stochastic %K 6%
Beta -2.43
Analysts Strong Sell
Price Target $10.50

Company Profile

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The comp...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 798 8589
Address:
2000 Sierra Point Parkway, Suite 400, Brisbane, United States
YieldYeah
YieldYeah Feb. 3 at 3:31 PM
$TPST There are some seriously smart and strategic players behind this merger: Angel, Brady, MTS, and Lotus Billionaire Brothers. I'm excited to see what the coming weeks and months will hold for us. I’m betting after the Closing 8K happens, Tempest 2.0 will have a series of PR’s ready for the market to reassess the value of the company's assets. The forced silence will be over soon and things could start to get really interesting!
1 · Reply
lousjamsession
lousjamsession Feb. 3 at 3:09 PM
1 · Reply
Xamayca
Xamayca Feb. 3 at 2:57 PM
$TPST Those selling are being robbed lol. Sorry for thinking out loud the point is something much better is in the offing! I may have to add a couple thousand here.
2 · Reply
Xamayca
Xamayca Feb. 3 at 2:42 PM
$TPST Is there not an issue of fraud! If TPST fails to make good on these warrants which think dived everybody into holding shares for in the case they do not make good
1 · Reply
JMALSH
JMALSH Feb. 3 at 2:36 PM
$TPST When will the warrents be traded?
1 · Reply
fantastex
fantastex Feb. 3 at 12:11 PM
$TPST whats the cash on hand here anybody knows?
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Feb. 3 at 6:00 AM
$TPST I recommend that if you are a Bull Buying Warrants and Shares, both, that you Buy the Warrants, first. Once you later Buy the Shares, this would help Rise Warrants Price (WP). It doesn't function as intended, trying it the other way. Buying Warrants does not directly affect Stock Price. Buying Shares DOES alter WP. Buy Warrants first, Bulls, when Buying both Warrants and Shares.
1 · Reply
Onedaytolive
Onedaytolive Feb. 3 at 4:44 AM
$TPST First of all, think about it. Why do you think that mean Sabi agreed to a $3.5 capital increase? Moreover, the risk of loss is high, and the stock price is actually $2.5. This fact itself is fundamentally strange.I've heard quite a huge story from Brady, Angel, and Fixer Lotus. It's also thanks to Sabi's nimble footwork that he can move nearly 5 million yen in a short period of time until the end of January.
0 · Reply
Onedaytolive
Onedaytolive Feb. 3 at 3:57 AM
$TPST At this point, I think we have a pretty good idea of the potential buyers. Companies that want to buy the 2003 dual CAR-T and mRNA × dual CAR-T platforms, the former TPST pipeline, and AZ's dual CAR-T with the option to crush it are probably this one, that one, and the other one. It would be even more interesting if AZ added to the price to protect its pipeline. Even if AZ does not enter the fray, the acquisition price is expected to easily exceed the $18 warrant.
1 · Reply
Onedaytolive
Onedaytolive Feb. 3 at 3:10 AM
$TPST Results of clinical trials involving 23 subjects in TPST-2003 https://ash.confex.com/ash/2024/webprogram/Paper201160.html?utm_source=chatgpt.com
2 · Reply
Latest News on TPST
Tempest Therapeutics shares end wild week with 8% drop

Oct 13, 2023, 4:13 PM EDT - 2 years ago

Tempest Therapeutics shares end wild week with 8% drop


Tempest Therapeutics shares head back to earth after 4,000% gain

Oct 12, 2023, 12:49 PM EDT - 2 years ago

Tempest Therapeutics shares head back to earth after 4,000% gain


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 2 years ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS AVTX MTNB


Tempest Adopts Limited Duration Stockholder Rights Plan

Oct 11, 2023, 8:01 AM EDT - 2 years ago

Tempest Adopts Limited Duration Stockholder Rights Plan


YieldYeah
YieldYeah Feb. 3 at 3:31 PM
$TPST There are some seriously smart and strategic players behind this merger: Angel, Brady, MTS, and Lotus Billionaire Brothers. I'm excited to see what the coming weeks and months will hold for us. I’m betting after the Closing 8K happens, Tempest 2.0 will have a series of PR’s ready for the market to reassess the value of the company's assets. The forced silence will be over soon and things could start to get really interesting!
1 · Reply
lousjamsession
lousjamsession Feb. 3 at 3:09 PM
1 · Reply
Xamayca
Xamayca Feb. 3 at 2:57 PM
$TPST Those selling are being robbed lol. Sorry for thinking out loud the point is something much better is in the offing! I may have to add a couple thousand here.
2 · Reply
Xamayca
Xamayca Feb. 3 at 2:42 PM
$TPST Is there not an issue of fraud! If TPST fails to make good on these warrants which think dived everybody into holding shares for in the case they do not make good
1 · Reply
JMALSH
JMALSH Feb. 3 at 2:36 PM
$TPST When will the warrents be traded?
1 · Reply
fantastex
fantastex Feb. 3 at 12:11 PM
$TPST whats the cash on hand here anybody knows?
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Feb. 3 at 6:00 AM
$TPST I recommend that if you are a Bull Buying Warrants and Shares, both, that you Buy the Warrants, first. Once you later Buy the Shares, this would help Rise Warrants Price (WP). It doesn't function as intended, trying it the other way. Buying Warrants does not directly affect Stock Price. Buying Shares DOES alter WP. Buy Warrants first, Bulls, when Buying both Warrants and Shares.
1 · Reply
Onedaytolive
Onedaytolive Feb. 3 at 4:44 AM
$TPST First of all, think about it. Why do you think that mean Sabi agreed to a $3.5 capital increase? Moreover, the risk of loss is high, and the stock price is actually $2.5. This fact itself is fundamentally strange.I've heard quite a huge story from Brady, Angel, and Fixer Lotus. It's also thanks to Sabi's nimble footwork that he can move nearly 5 million yen in a short period of time until the end of January.
0 · Reply
Onedaytolive
Onedaytolive Feb. 3 at 3:57 AM
$TPST At this point, I think we have a pretty good idea of the potential buyers. Companies that want to buy the 2003 dual CAR-T and mRNA × dual CAR-T platforms, the former TPST pipeline, and AZ's dual CAR-T with the option to crush it are probably this one, that one, and the other one. It would be even more interesting if AZ added to the price to protect its pipeline. Even if AZ does not enter the fray, the acquisition price is expected to easily exceed the $18 warrant.
1 · Reply
Onedaytolive
Onedaytolive Feb. 3 at 3:10 AM
$TPST Results of clinical trials involving 23 subjects in TPST-2003 https://ash.confex.com/ash/2024/webprogram/Paper201160.html?utm_source=chatgpt.com
2 · Reply
ManiacalSlug
ManiacalSlug Feb. 2 at 8:17 PM
$TPST People understandably exiting after assumed warrant issue date, probably will break the $2.40 all-time low but with 15 million shares including the Sabby warrants if they ever issue, I think the Factor assets are likely worth the $30 million they paid. So $2 might actually be a good entry point considering the circa $10 million cash and valuing TPST assets at zero. Lots of newsgroups that could change that quickly. Infact any newsgroup of any kind, or even a statement from Brady or Angel. There has to be something somewhere it this that is not worst case scenario!?
3 · Reply
Xamayca
Xamayca Feb. 2 at 7:51 PM
$TPST Expecting an upturned of day maybe even a greening!?
0 · Reply
Xamayca
Xamayca Feb. 2 at 7:49 PM
$TPST Brad(y) is sad he had no more money to add while his company’s looking bad. This look bad that Brad(y) and his buddy’s didn’t add what happened to the hopes they had? Ya slow day!
0 · Reply
Thestokinator
Thestokinator Feb. 2 at 6:30 PM
$TPST this has turned into a complete mess! Still holding 20K shares and shit load of warrants now which seem useless as I don't see this hitting above 20 in next 5 years! Great science but more dilution in future..... Should have done offering when it was 5 dollars now almost 2 years ago and another one when it was 12 on ph2 readout! Se used cash and started ph3. So far big time up here and not holding much in comparison historic at one point 520k shares before ph2 readout. So messy I have no idea what is happening anymore lol😒.
2 · Reply
brotherearl
brotherearl Feb. 2 at 3:40 PM
$TPST BRADY = total piece crap..... 2025. this year no better!
3 · Reply
GJ_Rockabilt
GJ_Rockabilt Feb. 2 at 2:20 PM
$TPST $CLLS $AZN Let the Bidding WAR begin!
0 · Reply
GJ_Rockabilt
GJ_Rockabilt Feb. 2 at 1:59 PM
$TPST Day One, the Tempest Warrants scheduled for Shareholders to get is expected to range $0.05 to $0.35, PERIOD.
1 · Reply
nafi
nafi Feb. 2 at 1:51 PM
$TPST Deferred. Stalled. By choice. Exciting week ahead.
1 · Reply
Onedaytolive
Onedaytolive Feb. 2 at 1:46 PM
$TPST The progress of the lawsuit filed by Angel CEO will also be a factor in TPST's BO. Currently, AZ is maintaining silence, but once it responds to the lawsuit in any way, the world will recognize this lawsuit as a fact. The only way for AZ to resolve this lawsuit is to buy TPST. What this means is that it is impossible for Angel CEO to buy a listed company and use mRNA technology by paying license fees, as he is conducting dual car-t research and development just like AZ. Furthermore, if a competitor buys TPST, AZ's mRNA × dual car-t could be in mortal danger. AZ and its subsidiaries have likely invested heavily in mRNA × dual car-t, so if they lose the lawsuit, AZ's stock price will take a big hit. In summary, if competition arises in the TPST BO, AZ will likely be in a position where it cannot back down. Of course, this is based on the premise that the 2003 p1 will be successful.
3 · Reply
GreylockSec
GreylockSec Feb. 2 at 1:40 PM
$TPST ...The Warrants will almost certainly be re-priced 👇 lower. They were set at the time to be approximately double the $9+ market price at that period in time. Now that the stock has been sitting for at least 30+ days in the $3-dollar range, I expect them to be re-priced in the late Winter to around the$6 ~ $8.00 range or so...But folks, this will not occur because they feel bad for us, or we always recycle our cans, or because we go to Church or the Synagogue on occasion... (Re-priced) dividend Warrants are simply another tool used to raise capital fast without doing an offering, and according to Tempest, are to be issued "to mitigate dilution of (legacy) shareholders." Re-pricing of Warrants has historically occurred before with Biodexa from$2.20 to $1.50, and with Ave Therapeutics from $116 down to $6 or so. This could help many of us burned shareholders to recoup some cash 💰at some point ☝️ if Brady and Dr. Angel can line up their ducks...
1 · Reply
JMALSH
JMALSH Feb. 2 at 4:47 AM
$TPST @frankyboyz please check this out
0 · Reply
Onedaytolive
Onedaytolive Feb. 2 at 1:03 AM
$TPST “KQ-2003 has demonstrated highly promising efficacy signals in ongoing clinical studies. Its parallel dual-target design offers significant advantages in mitigating relapse risk and overcoming efficacy heterogeneity, filling key gaps in existing CAR-T therapies,” said Matt Angel , CEO of Erigen. “Leveraging our deep experience in universal CAR-T development and commercialization, along with strategic support from leading global investors, we will rapidly advance multicenter clinical trials for KQ-2003 outside Greater China and simultaneously initiate development of the next-generation universal CAR-T to bring more accessible and innovative cell therapy options to patients with cancer and autoimmune diseases worldwide.” The collaboration aims to address challenges of relapse and suboptimal efficacy in certain hematologic malignancies.
1 · Reply